The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven‐Valent Pneumococcal Conjugate Vaccine

Abstract

The burden of pneumococcal disease before routine use of the pneumococcal conjugate vaccine was substantial in all age groups of the Canadian population. This estimate provides a baseline for further analysis of the direct and indirect impacts of the vaccine.